Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

4-aminopyridine-a review.

N Soni, P Kam

    Anaesthesia and Intensive Care
    |May 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    4-aminopyridine, a potassium channel blocker, enhances neurotransmitter release at nerve terminals. It shows therapeutic potential in neuromuscular disorders like myasthenia gravis and Eaton Lambert syndrome, despite central nervous system side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Frailty, Geriatric Impairments, and Quality of Life in Older Cancer Survivors Compared to Age-Matched Non-Cancer Controls.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026
    Same author

    Update from the 5th Edition of the WHO Classification of Nasal, Paranasal, and Skull Base Tumors: Imaging Overview with Histopathologic and Genetic Correlation.

    AJNR. American journal of neuroradiology·2023
    Same author

    Unpacking the CNS Manifestations of Epstein-Barr Virus: An Imaging Perspective.

    AJNR. American journal of neuroradiology·2023
    Same author

    Amino Acid Tracer PET MRI in Glioma Management: What a Neuroradiologist Needs to Know.

    AJNR. American journal of neuroradiology·2023
    Same author

    Diagnostic Performance of PET and Perfusion-Weighted Imaging in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature.

    AJNR. American journal of neuroradiology·2020
    Same author

    Retrospective, dual-centre review of imaging findings in neurosarcoidosis at presentation: prevalence and imaging sub-types.

    Clinical radiology·2020
    Same journal

    A brief history of colour in the operating theatre.

    Anaesthesia and intensive care·2026
    Same journal

    Evaluating the completeness of perioperative outcome metrics in electronic medical records: Insights based on the proposed Perioperative Clinical Outcomes Registry framework.

    Anaesthesia and intensive care·2026
    Same journal

    Large language model prompt engineering for medical education: A practical guide for the Australian and New Zealand College of Anaesthetists Final Examination.

    Anaesthesia and intensive care·2026
    Same journal

    Nitrous oxide added at the end of sevoflurane anaesthesia hastens emergence and eliminates prolonged time to extubation (SEVONATE study): A randomised controlled trial.

    Anaesthesia and intensive care·2026
    Same journal

    Complications related to arterial line catheters and monitoring reported to webAIRS, 2009-2023.

    Anaesthesia and intensive care·2026
    Same journal

    A summary guide for detecting and reducing nitrous oxide infrastructure leaks in healthcare facilities.

    Anaesthesia and intensive care·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Neuroscience

    Background:

    • 4-aminopyridine is the first aminopyridine used clinically.
    • It functions by blocking potassium channels, enhancing neurotransmitter release.

    Purpose of the Study:

    • To review the clinical applications and effects of 4-aminopyridine.
    • To evaluate its efficacy in various neuromuscular and neurological conditions.

    Main Methods:

    • Literature review of clinical studies and pharmacological actions.
    • Analysis of 4-aminopyridine's effects on the neuromuscular junction and central nervous system.

    Main Results:

    • 4-aminopyridine significantly impacts the neuromuscular junction in humans.
    • It shows potential in reversing nondepolarizer blockade and treating myasthenia gravis and Eaton Lambert syndrome.

    Related Experiment Videos

  • Central nervous system effects, including tremor and convulsions, are notable side effects.

    • Conclusions:

    • 4-aminopyridine is a valuable therapeutic agent for specific neuromuscular conditions.
    • Its clinical utility is balanced by significant central nervous system side effects that require careful management.